- Home
- YOU vs NNNN Comparison
YOU vs NNNN Comparison
Compare YOU & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- NNNN
- Stock Information
- Founded
- YOU 2010
- NNNN 2021
- Country
- YOU United States
- NNNN Germany
- Employees
- YOU N/A
- NNNN N/A
- Industry
- YOU Computer Software: Prepackaged Software
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- YOU Technology
- NNNN Health Care
- Exchange
- YOU Nasdaq
- NNNN Nasdaq
- Market Cap
- YOU 2.3B
- NNNN 2.2B
- IPO Year
- YOU 2021
- NNNN 2025
- Fundamental
- Price
- YOU $30.29
- NNNN $43.00
- Analyst Decision
- YOU Strong Buy
- NNNN
- Analyst Count
- YOU 4
- NNNN 0
- Target Price
- YOU $33.50
- NNNN N/A
- AVG Volume (30 Days)
- YOU 1.6M
- NNNN 203.8K
- Earning Date
- YOU 08-05-2025
- NNNN 01-01-0001
- Dividend Yield
- YOU 2.58%
- NNNN N/A
- EPS Growth
- YOU 182.03
- NNNN N/A
- EPS
- YOU 1.59
- NNNN 0.06
- Revenue
- YOU $802,807,000.00
- NNNN $8,185,146.00
- Revenue This Year
- YOU $14.81
- NNNN N/A
- Revenue Next Year
- YOU $10.46
- NNNN N/A
- P/E Ratio
- YOU $18.74
- NNNN $780.77
- Revenue Growth
- YOU 21.59
- NNNN 21.95
- 52 Week Low
- YOU $18.23
- NNNN $5.18
- 52 Week High
- YOU $38.88
- NNNN $55.65
- Technical
- Relative Strength Index (RSI)
- YOU 64.44
- NNNN N/A
- Support Level
- YOU $28.21
- NNNN N/A
- Resistance Level
- YOU $31.55
- NNNN N/A
- Average True Range (ATR)
- YOU 0.87
- NNNN 0.00
- MACD
- YOU 0.04
- NNNN 0.00
- Stochastic Oscillator
- YOU 60.60
- NNNN 0.00
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.